Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Argus Health
Covington
Harvard Business School
Cipla
QuintilesIMS
US Army
Medtronic
Boehringer Ingelheim
Accenture

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040866

« Back to Dashboard
NDA 040866 describes PRIMIDONE, which is a drug marketed by Lannett, Impax Labs, Anda Repository, Watson Labs, Dr Reddys Labs Ltd, Amneal Pharm, Hikma Intl Pharms, and Vintage Pharms, and is included in nine NDAs. It is available from seventeen suppliers. Additional details are available on the PRIMIDONE profile page.

The generic ingredient in PRIMIDONE is primidone. There are seven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the primidone profile page.

Summary for NDA: 040866

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details

Pharmacology for NDA: 040866

Suppliers and Packaging for NDA: 040866

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PRIMIDONE
primidone
TABLET;ORAL 040866 ANDA Major Pharmaceuticals 0904-6207 0904-6207-60 100 TABLET in 1 BOTTLE (0904-6207-60)
PRIMIDONE
primidone
TABLET;ORAL 040866 ANDA AvKARE, Inc. 42291-509 42291-509-50 500 TABLET in 1 BOTTLE (42291-509-50)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Apr 23, 2008TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Apr 23, 2008TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
UBS
Baxter
Fish and Richardson
Covington
Johnson and Johnson
McKinsey
US Army
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot